India is the source of most of the generic drugs used in the developing world. It can only do this thanks to its flexible patent laws. But today, through a new free trade agreement, the European Union is seeking to impose new restrictions on Indian intellectual property law, posing a threat to the production and to the export to the developing world of generic drugs at affordable prices.

Related News & Publications